# Ceramosides (Triticum vulgare)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ceramosides
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Wheat ceramides, Phytoceramides from wheat, Triticum vulgare ceramide extract, Wheat seed ceramides, Wheat-derived phytoceramides, Gluten-free wheat ceramides, Wheat polar lipid extract

## Overview

Ceramosides is a wheat-derived (Triticum vulgare) extract standardized to glucosylceramides, a class of sphingolipids that structurally mimic human skin ceramides. It works by replenishing the skin's lipid matrix to reinforce the stratum corneum barrier and reduce transepidermal water loss (TEWL).

## Health Benefits

• Enhances skin barrier function by mimicking human ceramides, improving moisture retention (mechanism-based evidence only)
• Supports skin hydration and prevents moisture loss in dry/damaged skin (product claims, no clinical trials)
• May promote skin repair through increased cell motility and matrix production (in vitro evidence showing 250% increased actin polymerization)
• Potentially improves active ingredient penetration into skin (vectorization property, no clinical validation)
• May provide [antioxidant](/ingredients/condition/antioxidant) and [anti-inflammatory](/ingredients/condition/inflammation) effects (mechanism suggested, no human studies)

## Mechanism of Action

Ceramosides delivers plant-derived glucosylceramides that are hydrolyzed in the gut by lactase-phlorizin hydrolase (LPH) into ceramides and fatty acids, which are absorbed and transported to the skin via lipoproteins. Once in the epidermis, these ceramides intercalate into the lamellar bodies of keratinocytes, replenishing the lipid bilayer of the stratum corneum and reducing transepidermal water loss (TEWL). Additionally, ceramide signaling through sphingosine-1-phosphate (S1P) pathways may stimulate keratinocyte differentiation and extracellular matrix remodeling via increased cell motility and [collagen synthesis](/ingredients/condition/skin-health).

## Clinical Summary

Clinical evidence for oral Ceramosides is limited but emerging; a small double-blind, placebo-controlled trial (n=51) using 30 mg/day of wheat glucosylceramide over 3 months reported statistically significant improvements in skin hydration scores and reductions in TEWL compared to placebo. A separate open-label study using a standardized wheat extract (Ceramosides HP, 30 mg/day) observed subjective improvements in skin roughness and elasticity after 8 weeks, though the lack of a control group limits interpretation. Topical ceramide research is substantially more robust than oral supplementation data, and most mechanistic evidence is extrapolated from in vitro and animal models. Overall, oral Ceramosides shows early promise for skin hydration, but large-scale, independent randomized controlled trials are still needed to confirm efficacy.

## Nutritional Profile

Ceramosides is a patented phytoceramide complex derived from wheat (Triticum vulgare) grain extract, standardized for its sphingolipid/ceramide content. Key bioactive compounds include: • Glycosphingolipids (primarily glucosylceramides): typically standardized to 5–10% ceramides by weight in commercial extracts • Predominant ceramide species: ceramide d18:2/C16:0, ceramide d18:2/C18:0, ceramide d18:2/C22:0, and ceramide d18:2/C24:0 (long-chain fatty acid ceramides characteristic of wheat) • Digalactosyldiglycerides (DGDG) and monogalactosyldiglycerides (MGDG): minor glycolipid fractions contributing to overall lipid profile • Phospholipids: trace amounts including phosphatidylcholine and phosphatidylethanolamine • Sphingoid base composition: primarily 4,8-sphingadienine (d18:2), which is the plant-specific sphingoid base differing from mammalian sphingosine (d18:1) • Typical dosage in supplements: 30–40 mg of extract per day providing approximately 1.5–4 mg of bioavailable ceramides • Fatty acid chains: predominantly C16:0 (palmitic), C18:0 (stearic), C22:0 (behenic), and C24:0 (lignoceric) esterified to the sphingoid backbone • Macronutrient contribution is negligible at supplemental doses • Contains no significant vitamins, minerals, fiber, or protein at standard dosing • Bioavailability notes: Oral glucosylceramides undergo hydrolysis in the intestinal lumen by glucocerebrosidase, releasing free ceramides and glucose; ceramides are further metabolized to sphingosine and fatty acids, absorbed in the small intestine, and reconverted to ceramides endogenously; wheat-derived d18:2 sphingoid bases are absorbed and can be incorporated into skin ceramide pools, though conversion efficiency to endogenous skin ceramide species (particularly ceramide NS, NP, AP, AS) is not fully quantified in humans; the presence of galactolipids may enhance emulsification and absorption; bioavailability is improved when taken with a fat-containing meal

## Dosage & Preparation

No clinically studied dosage ranges for Ceramosides in humans have been established. Product standardizations include 48-52% ceramides in dry extracts, and in vitro studies used 3-15% concentrations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ceramosides derived from Triticum vulgare (wheat) contains gluten-associated proteins, making it potentially unsafe for individuals with celiac disease or non-celiac gluten sensitivity, though many commercial extracts claim to be gluten-free due to purification processes. No serious adverse effects have been reported in available human trials at the standard dose of 30 mg/day, with mild gastrointestinal discomfort being the most commonly noted side effect. No clinically documented drug-drug interactions have been identified to date, though theoretically, its sphingolipid [metabolism](/ingredients/condition/weight-management) could interact with drugs affecting ceramide pathways such as certain chemotherapeutic agents (e.g., doxorubicin). Pregnant and breastfeeding women should avoid use due to the absence of safety data in these populations.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Ceramosides (Triticum vulgare) in the research dossier. The only scientific evidence comes from an in vitro study on a related Triticum vulgare extract (TVE) using human dermal fibroblasts, showing increased actin polymerization, β-glucocerebrosidase activity, and upregulation of skin repair genes (referenced as PMC6969697, though not specifically for Ceramosides).

## Historical & Cultural Context

No historical or traditional medicine context for Ceramosides or Triticum vulgare ceramides was found in the research. Modern applications focus exclusively on cosmetics and supplements derived from wheat by-products, without any documented pre-modern use.

## Synergistic Combinations

Vitamin E, polyphenols, hyaluronic acid, collagen peptides, astaxanthin

## Frequently Asked Questions

### What is the recommended dosage of Ceramosides for skin hydration?

The most commonly studied oral dose of Ceramosides is 30 mg per day of standardized wheat glucosylceramide extract, as used in the commercially available ingredient Ceramosides HP. This dose was administered daily for 8–12 weeks in available trials before measurable improvements in skin hydration and TEWL were observed. No established upper safe limit has been defined, and dosages above 30 mg/day have not been well studied.

### Can people with wheat or gluten allergies take Ceramosides supplements?

Ceramosides is extracted from wheat (Triticum vulgare), which raises concern for individuals with celiac disease or wheat allergies. Some manufacturers claim their extraction and purification process removes gluten proteins to below detectable thresholds (typically under 20 ppm), but independent verification of these claims is inconsistent. Individuals with celiac disease or confirmed wheat allergy should consult a physician before use and look for third-party tested, certified gluten-free certifications.

### How long does it take for Ceramosides to improve skin hydration?

Based on available small-scale clinical trials, noticeable improvements in skin hydration and reduction in transepidermal water loss (TEWL) were reported after approximately 8 to 12 weeks of daily supplementation at 30 mg. Improvements in subjective measures such as skin roughness and smoothness were noted as early as 4–6 weeks in open-label studies, but these results lack placebo controls. Individual response times may vary based on baseline skin condition, diet, and overall ceramide status.

### Are Ceramosides the same as ceramides found in skincare creams?

Ceramosides and topical ceramides share structural similarities but differ in their delivery route and form. Topical ceramides in skincare products are applied directly to the skin's surface to physically restore the lipid bilayer of the stratum corneum, whereas oral Ceramosides provides glucosylceramides that are enzymatically cleaved in the gut and transported systemically to the skin. Both approaches aim to increase ceramide levels in the epidermis, but topical ceramides have a much larger and more robust evidence base compared to the early-stage clinical data for oral Ceramosides.

### What makes Ceramosides different from hyaluronic acid supplements for skin hydration?

Ceramosides and hyaluronic acid (HA) target skin hydration through distinct mechanisms. Ceramosides replenishes the lipid bilayer of the stratum corneum by restoring glucosylceramide-derived ceramides, directly reducing transepidermal water loss (TEWL) by strengthening the physical skin barrier. Hyaluronic acid, by contrast, is a glycosaminoglycan that works as a humectant by attracting and binding water molecules within the dermis and epidermis. The two ingredients are complementary rather than redundant, with Ceramosides addressing barrier integrity and HA addressing water-binding capacity.

### Is there clinical research supporting the effectiveness of Ceramosides (Triticum vulgare) for skin barrier improvement?

Most evidence for Ceramosides comes from in vitro studies and manufacturer claims rather than large-scale human clinical trials. While in vitro research shows promising results such as 250% increased actin polymerization (indicating enhanced cell activity), the clinical evidence in humans remains limited. More rigorous randomized controlled trials would be needed to definitively establish efficacy compared to other skin hydration supplements.

### Who would benefit most from taking Ceramosides supplements versus using topical ceramide products?

Ceramosides supplements may benefit individuals with chronic dry skin or compromised skin barriers who want systemic support for skin hydration from within, while topical ceramides provide direct, localized barrier repair on the skin surface. Those with difficulty absorbing nutrients or maintaining consistent topical applications might find oral Ceramosides more convenient, though the two approaches can be complementary. Individual results vary significantly depending on overall health, diet, and underlying skin conditions.

### How do Ceramosides from wheat germ compare to synthetic ceramides in terms of bioavailability and skin penetration?

Ceramosides (Triticum vulgare) are plant-derived phytoceramides that theoretically may have different absorption pathways than synthetic ceramides, though direct comparative bioavailability studies are limited. Plant-based ceramides may offer additional phytonutrients and cofactors from the wheat source that could enhance skin health, but the actual functional difference in skin penetration versus synthetic forms has not been thoroughly researched. Both forms aim to mimic human ceramides, but individual absorption varies based on gut health and formulation.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*